These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8720635)

  • 1. Resolved: autistic children should have a trial of naltrexone.
    Campbell M; Harris JC
    J Am Acad Child Adolesc Psychiatry; 1996 Feb; 35(2):246-9; discussion 249-51. PubMed ID: 8720635
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone in young autistic children: replication study and learning measures.
    Kolmen BK; Feldman HM; Handen BL; Janosky JE
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1570-8. PubMed ID: 9394942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled acute dosage naltrexone study in young autistic children.
    Willemsen-Swinkels SH; Buitelaar JK; Weijnen FG; van Engeland H
    Psychiatry Res; 1995 Oct; 58(3):203-15. PubMed ID: 8570776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone in children with autism.
    Buitelaar JK; Willemsen-Swinkels S; Van Engeland H
    J Am Acad Child Adolesc Psychiatry; 1998 Aug; 37(8):800-2. PubMed ID: 9695440
    [No Abstract]   [Full Text] [Related]  

  • 6. Naltrexone and communication skills in young children with autism.
    Feldman HM; Kolmen BK; Gonzaga AM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):587-93. PubMed ID: 10230191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of naltrexone on automutilation behavior in autistic psychosis].
    Decocq G; Kandelaft N; Compagnon M
    Presse Med; 1996 Feb; 25(7):305. PubMed ID: 8685173
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Sablaban IM; Sivananthan M
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):620. PubMed ID: 33146546
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.
    Scifo R; Cioni M; Nicolosi A; Batticane N; Tirolo C; Testa N; Quattropani MC; Morale MC; Gallo F; Marchetti B
    Ann Ist Super Sanita; 1996; 32(3):351-9. PubMed ID: 9028057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.
    Bouvard MP; Leboyer M; Launay JM; Recasens C; Plumet MH; Waller-Perotte D; Tabuteau F; Bondoux D; Dugas M; Lensing P
    Psychiatry Res; 1995 Oct; 58(3):191-201. PubMed ID: 8570775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone in autistic children: a double-blind and placebo-controlled study.
    Campbell M; Anderson LT; Small AM; Locascio JJ; Lynch NS; Choroco MC
    Psychopharmacol Bull; 1990; 26(1):130-5. PubMed ID: 2196621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate antagonists in children and adolescents.
    Chabane N; Leboyer M; Mouren-Simeoni MC
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I44-50. PubMed ID: 11140779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Opiate hypothesis of the origin of early childhood autism and sequelae for psychopharmacotherapy].
    Lensing P; Klingler D; Panksepp J; Huber M; Saria A; Hackenberg B; Adam H
    Z Kinder Jugendpsychiatr; 1992 Sep; 20(3):185-96. PubMed ID: 1329399
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?
    Good P
    Med Hypotheses; 2006; 67(3):671-2. PubMed ID: 16759815
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
    Ernst M; Devi L; Silva RR; Gonzalez NM; Small AM; Malone RP; Campbell M
    Psychopharmacol Bull; 1993; 29(2):221-7. PubMed ID: 8290669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactivity and ADHD.
    Adesman AR
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1262. PubMed ID: 8885579
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children.
    Cazzullo AG; Musetti MC; Musetti L; Bajo S; Sacerdote P; Panerai A
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):361-6. PubMed ID: 10422898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.